DIAGNOSTIC VALUE OF CARTILAGE OLIGOMERIC MATRIX PROTEIN IN CONNECTIVE TISSUE DISEASE


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

The paper gives data on the diagnostic value of cartilage oligomeric matrix protein in connective tissue disease. The authors briefly outline the results of their own investigation aimed at determining the level of this protein as a biomarker of cartilage metabolism in children with hip dysplasia.

全文:

受限制的访问

作者简介

Yu. Belova

V.I. Razumovsky Saratov State Medical University

Email: sarniito_bsv@mail.ru

E. Gladilin

V.I. Razumovsky Saratov State Medical University

Email: sarniito_bsv@mail.ru

参考

  1. Энгельс Ф. Диалектика природы / М.: Политическая литература, 1975.
  2. Соколова О.С. Протеомные исследования в биологии и медицине. Методическое пособие / М.: Изд-во: МГУ им. М.В. Ломоносова, 2005.
  3. Andersson M., Svensson B., Petersson I. et al. Early increase in serum-COMP is associated with joint damage progression over the first five years in patients with rheumatoid arthritis // BMC Musculoskelet Disord. - 2013; 2 (14): 229.
  4. Happonen K., Saxne T., Jacobsson L. et al. COMP-C3b complexes in rheumatoid arthritis with severe extraarticular manifestations // J. Rheumatol. -2013; 40 (12): 2001-5.
  5. Hidayat R., Isbagio H., Setyohadi B. et al. Correlation between receptor activator of nuclear factor-Kß ligand (RANKL), and osteoprotegerin (OPG) with cartilage degradation in rheumatoid arthritis patients // Acta Med. Indones. - 2014; 46 (1): 24-9.
  6. Christensen A., Lindegaard H., Horslev-Petersen K. et al. Cartilage oligomeric matrix protein associates differentially with erosions and synovitis and has a different temporal course in cyclic citrullinated peptide antibody (anti-CCP)-positive versus anti-CCP-negative early rheumatoid arthritis // J. Rheumatol. - 2011; 38 (8): 1563-8.
  7. Houseman M., Potter C., Marshall N. et al. Baseline serum MMP-3 levels in patients with Rheumatoid Arthritis are still independently predictive of radiographic progression in a longitudinal observational cohort at 8 years follow up // Arthritis Res Ther. - 2012; 14 (1): R30.
  8. Niki Y., Takeuchi T., Nakayama M. et al. Clinical significance of cartilage biomarkers for monitoring structural joint damage in rheumatoid arthritis patients treated with anti-TNF therapy // PLoS One. - 2012; 7 (5): e37447.
  9. Mobasheri A. Osteoarthritis year 2012 in review: biomarkers // Osteoarthritis Cartilage. - 2012; 20 (12): 1451-64.
  10. Lotz M., Martel-Pelletier J., Christiansen C. et al. Value of biomarkers in osteoarthritis: current status and perspectives // Ann. Rheum. Dis. - 2013; 72 (11): 1756-63.
  11. Wang X., Zheng Y., Cao Y. et al. Study on the diagnostic value of whole-organ magnetic resonance imaging score (WORMS) in knee osteoarthritis // Zhongguo Gu Shang. - 2012; 25 (5): 364-8.
  12. Williams F., Spector T. Biomarkers in osteoarthritis // Arthritis Res. Ther. -2008; 10 (1): 101.
  13. Li H., Wang D., Wu Z. et al. Serum levels of cartilage oligomeric matrix protein in the diagnosis of knee osteoarthritis // Zhongguo Gu Shang. - 2012; 25 (5): 380-3.
  14. Verma P., Dalal K. Serum cartilage oligomeric matrix protein (COMP) in knee osteoarthritis: a novel diagnostic and prognostic biomarker // J. Orthop. Res. -2013; 31 (7): 999-1006.
  15. Addison S., Coleman R., Feng S. et al. Whole-body bone scintigraphy provides a measure of the total-body burden of osteoarthritis for the purpose of systemic biomarker validation // Arthritis Rheum. - 2009; 60 (11): 3366-73.
  16. Vos L., Kuijer R., Huddleston Slater J. et al. Inflammation is more distinct in temporomandibular joint osteoarthritis compared to the knee joint // J. Maxillofac. Surg. - 2014; 72 (1): 35-40.
  17. Светлова М.С. Гонартроз ранних стадий: клинико-инструментальная, лабораторная характеристика и болезнь-модифицирующая терапия. Автореф. дис.. д-ра мед. наук. Ярославль, 2009.
  18. Zivanovic S., Rackov L., Zivanovic A. Cartilage oligomeric matrix protein -inflammation biomarker in knee osteoarthritis // Bosn. J. Basic Med. Sci. - 2011; 11 (1): 27-32.
  19. Posey K., Hecht J. The role of cartilage oligomeric matrix protein (COMP) in skeletal disease // Curr. Drug Targets. - 2008; 9 (10): 869-77.
  20. Спиридонов Н.А. Медико-социальные последствия у больных с врожденным вывихом бедра и современные подходы к их реабилитации. Автореф. дис.. канд. мед. наук. М., 2011.

补充文件

附件文件
动作
1. JATS XML

版权所有 © Russkiy Vrach Publishing House, 2017
##common.cookie##